Editorial

Investigational ADC Shows Promise for Patients with Metastatic HER2-positive Breast Cancer

Data from a Phase I clinical trial of MM-302 (Merrimack Pharmaceuticals) presented at the annual meeting of the American...

Developing a New BiTe against Acute Myeloid Leukemia

Astellas Pharma Inc. (Tokyo, Japan) and The University of Texas MD Anderson Cancer Center (Houston, Texas) have signed an option...

How to Design Clinical Trials in the Era of Targeted Therapies

Antibody–drug conjugates or ADCs are a burgeoning class of targeted therapies designed to deliver dual therapies in a single,...

A New Dawn

It's a new dawn. It's a new day.These powerful words in one of my favorite songs ("Feeling Good") by...

ADCT-301 – A Novel Antibody-drug Conjugate Against Lymphomas – Moves Into Phase I Clinical...

ADC Therapeutics Sarl (Epalinges, Switzerland), a company involved in the development of antibody-drug conjugates against solid and hematological cancers, has filed an...

Positive Toxicology & Production Data on ADCs Generated with SMARTag™ Technology

Over the last decades antibody drug conjugates have received much attention.  This is, in part, due to their huge...

Immuno-Oncology SEA-CD40 Moves Into Phase I Clinical Trial for Advanced Solid Tumors

Earlier today, Seattle Genetics Inc, announced the initiation of a new Phase I clinical trial of SEA-CD40, which utilizes...

The Business of Bispecific Antibodies: Generating Focused Development Libraries

Bispecific antibodies (BsAb), widely used in the development of anticancer immunotherapy, are proteins capable of simultaneously binding two different...

Sanofi and Catalent Develop Next-Gen ADCs with SMARTag Technology

Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

Advancing Immunotherapy and the Future of Care: Nantworks Collaborates with Sorrento Therapeutics and Phoenix...

NantWorks, LLC, a California-based medical technology company and Sorrento Therapeutics, Inc, an oncology company developing new, targeted, treatments for cancer,...

FEATURED RESOURCES